A Phase III Study of 131I Metaiodobenzylguanidine (131I-MIBG) or Crizotinib Added t Intensive Therapy for Children With Newly Diagnosed High-Risk Neuroblastoma (NBL)

Project: Research project

Project Details

Description

A Phase III Study of 131I Metaiodobenzylguanidine (131I-MIBG) or Crizotinib Added t Intensive Therapy for Children With Newly Diagnosed High-Risk Neuroblastoma (NBL)
StatusActive
Effective start/end date1/1/1912/31/21

Funding

  • Children's Hospital of Philadelphia

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.